✦ LIBER ✦

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

✍ Scribed by Ching-Lung Lai; Anna Suk-Fong Lok; Pui-Chee Wu; Gerald Chee-Bunn Chan; Hsiang-Ju Lin

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 532 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880801)62:3<479::aid-cncr2820620306>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interferon-α in inoperable h

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

✍ Dr. Ching-Lung Lai; Johnson Y. N. Lau; Pui-Chee Wu; Henry Ngan; Hau-Tim Chung; S 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

To evaluate the clinical efficacy of interferon-a in hepatocellular carcinoma, 71 adult Chinese patients with histologically proven inoperable hepatocellular carcinoma were randomized to receive recombinant interferon-%,, (50 x lo6 IU/m2) intramuscularly three times a week (n = 35) or no antitumor t

A randomized trial of doxorubicin versus

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

✍ Katsutaro Shimaoka; David A. Schoenfeld; William D. Dewys; Richard H. Creech; Ro 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 2 views

A prospective randomized trial of doxoru

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

✍ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea

Preoperative short-term radiation therap

Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomized trial

✍ Stockholm Rectal Cancer Study Group 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

Liposome-encapsulated doxorubicin compar

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

✍ Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Noza 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Prospective randomized trial of chemoemb

Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled–iodized oil in the treatment of hepatocellular carcinoma

✍ J Raoul; D Guyader; J Bretagne; J Heautot; R Duvauferrier; P Bourguet; D Bekhech 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

Intra-arterial injection of radioactive Lipiodol has shown promising results in patients with hepatocellular carcinoma (HCC) and portal obstruction. The aim of this prospective, randomized trial was to compare the efficacy and tolerance of 131I-labeled Lipiodol and chemoembolization for the treatmen